Specifically, for IGF-IIsT, we refer to all cancers positive for IGF-II secretion (usually displaying various degrees of dedifferentiation associated with a high IRA/IRB expression ratio), which confers malignant and aggressive tumor behavior. This evidence concerns the gene IGF2 and cancer.